Trulieve Cannabis Corp
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| TRULIEVE CANNABIS CORP. | ||
| Date: February 29, 2024 | By: | /s/ Kim Rivers |
|---|---|---|
| Kim Rivers | ||
| Chief Executive Officer | ||
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each individual whose signature appears below constitutes and appoints each of Kim Rivers, Wes Getman and Joy Malivuk as such person’s true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for such person in such person’s name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other and all documents in connection therewith, with the U.S. Securities and Exchange Commission, granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that any said attorney-in-fact and agent, or any substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Kim Rivers | Director, Chief Executive Officer | February 29, 2024 |
| Kim Rivers | (Principal Executive Officer) | |
| /s/ Wes Getman | Chief Financial Officer | February 29, 2024 |
| Wes Getman | (Principal Financial Officer) | |
| /s/ Joy Malivuk | Chief Accounting Officer | February 29, 2024 |
| Joy Malivuk | (Principal Accounting Officer) | |
| /s/ Thad Beshears | Director | February 29, 2024 |
| Thad Beshears | ||
| /s/ Peter Healy | Director | February 29, 2024 |
| Peter Healy | ||
| /s/ Richard May | Director | February 29, 2024 |
| Richard May | ||
| /s/ Thomas Millner | Director | February 29, 2024 |
| Thomas Millner | ||
| /s/ Jane Morreau | Director | February 29, 2024 |
| Jane Morreau | ||
| /s/ Gianella Alvarez | Director | February 29, 2024 |
| Gianella Alvarez | ||
| /s/ Susan Thronson | Director | February 29, 2024 |
| Susan Thronson | ||
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Audited Financial Statements | |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 688) | F-2 |
| Report of Independent Registered Public Accounting Firm on Internal Control over Financial Reporting (PCAOB ID No. 688) | F-5 |
| Consolidated Balance Sheets as of December 31, 2023 and 2022 | F-7 |
| Consolidated Statements of Operations for the Years Ended December 31, 2023, 2022 and 2021 | F-8 |
| Consolidated Statements of Changes in Shareholders’ Equity for the Years Ended December 31, 2023, 2022 and 2021 | F-9 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2023, 2022 and 2021 | F-11 |
| Notes to Consolidated Financial Statements | F-12 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.